999174026	999174026	CD	B-NP	O
|	|	NN	I-NP	O
WVHO	WVHO	NN	I-NP	O
|	|	NN	I-NP	O
37014858	37014858	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8401163	8401163	CD	B-NP	O
|	|	CC	I-NP	O
4/16/2004	4/16/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/1/2004	7/1/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/19/2004	10/19/2004	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
DUDLEY	DUDLEY	NNP	B-NP	O
SPERL	SPERL	NNP	I-NP	O
MD	MD	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	NNP	B-NP	O
ILLNESS	ILLNESS	NNP	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
66-year-old	66-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
one	one	CD	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
constipated	constipate	VBN	I-VP	O
for	for	IN	B-PP	O
seven	seven	CD	B-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
on	on	IN	B-PP	O
10/17/04	10/17/04	CD	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
high	high	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
gallstones	gallstone	NNS	B-NP	O
and	and	CC	I-NP	O
diverticuli	diverticuli	NNS	I-NP	O
.	.	.	O	O

PAST	PAST	NN	B-NP	O
SURGICAL	SURGICAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Nonsignificant	Nonsignificant	JJ	B-ADJP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Avandia	Avandia	NNP	B-NP	O
4	4	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
lisinopril	lisinopril	VBP	B-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Hytrin	Hytrin	NN	B-NP	O
one	one	CD	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NN	B-NP	B-protein
80	80	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
x1	x1	NN	I-NP	I-protein
,	,	,	O	O
spironolactone	spironolactone	NN	B-NP	B-protein
25	25	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
x3	x3	NN	I-NP	I-protein
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Lipitor	Lipitor	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
x1	x1	NN	I-NP	I-protein
,	,	,	O	O
Flovent	Flovent	NNP	B-NP	O
,	,	,	O	O
Bextra	Bextra	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
x1	x1	NN	I-NP	O
,	,	,	O	O
Nexium	Nexium	NN	B-NP	B-protein
20	20	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
x1	x1	NN	I-NP	I-protein
,	,	,	O	O
Humulin	Humulin	NNP	B-NP	O
22	22	CD	I-NP	O
units	unit	NNS	I-NP	O
q.a.m.	q.a.m.	NN	B-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
baby	baby	NN	B-NP	O
aspirin	aspirin	NN	I-NP	O
81	81	CD	B-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
this	this	DT	B-NP	O
reason	reason	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
chest	ch	JJS	I-NP	O
x-ray	x-ray	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
showed	show	VBD	B-VP	O
free	free	JJ	B-NP	O
air	air	NN	I-NP	O
below	below	IN	B-PP	O
the	the	DT	B-NP	O
diaphragm	diaphragm	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
KUB	KUB	NN	I-NP	B-protein
showed	show	VBD	B-VP	O
dilated	dilated	JJ	B-NP	O
small	small	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
CT	CT	NN	I-NP	O
showed	show	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
free	free	JJ	I-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
this	this	DT	B-NP	O
reason	reason	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
brought	bring	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
OR	OR	NN	I-NP	O
on	on	IN	B-PP	O
10/17/04	10/17/04	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
day	day	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
exploratory	exploratory	JJ	B-NP	O
laparotomy	laparotomy	NN	I-NP	O
and	and	CC	I-NP	O
appendectomy	appendectomy	NN	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
diagnosed	diagnose	VBN	I-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
perforated	perforate	VBN	B-NP	O
appendicitis	appendicitis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
surgery	surgery	NN	I-NP	O
was	be	VBD	B-VP	O
uncomplicated	uncomplicated	JJ	B-ADJP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
afterwards	afterwards	RB	B-ADVP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
SICU	SICU	NN	I-NP	B-DNA
.	.	.	O	O

Please	Please	NN	B-NP	B-protein
refer	refer	VBP	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
interim	interim	JJ	I-NP	O
dictation	dictation	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
SICU	SICU	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
SICU	SICU	NN	I-NP	B-DNA
,	,	,	O	O
mainly	mainly	RB	B-ADVP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
three	three	CD	B-NP	O
problems	problem	NNS	I-NP	O
and	and	CC	B-PP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
reason	reason	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
kept	keep	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
unit	unit	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
rapid	rapid	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
oliguria	oliguria	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
confusion	confusion	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
back	back	RB	B-ADVP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
on	on	IN	B-PP	O
2/5/04	2/5/04	CD	B-NP	O
on	on	IN	B-PP	O
no	no	DT	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
with	with	IN	B-PP	O
NG	NG	NN	B-NP	O
tube	tube	NN	I-NP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
and	and	CC	B-PP	O
through	through	IN	B-PP	O
this	this	DT	B-NP	O
NG	NG	NN	I-NP	O
tube	tube	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
fed	feed	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
speech	speech	NN	B-NP	O
and	and	CC	O	O
swallow	swallow	VB	B-VP	O
evaluation	evaluation	NN	B-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
Speech	Speech	NNP	I-NP	O
&	&	CC	I-NP	O
Swallow	Swallow	NNP	I-NP	O
cleared	clear	VBD	B-VP	O
her	her	PRP	B-NP	O
for	for	IN	B-PP	O
mechanical	mechanical	JJ	B-NP	O
soft	soft	JJ	I-NP	O
diet	diet	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
NG	NG	NN	I-NP	O
tube	tube	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
postoperative	postoperative	JJ	I-NP	O
course	course	NN	I-NP	O
mainly	mainly	RB	B-ADVP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
characterized	characterize	VBN	I-VP	O
by	by	IN	B-PP	O
slow	slow	JJ	B-NP	O
recovery	recovery	NN	I-NP	O
and	and	CC	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
mental	mental	JJ	B-NP	O
confusion	confusion	NN	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
presence	presence	NN	B-NP	O
of	of	IN	B-PP	O
flatus	flatus	NN	B-NP	O
,	,	,	O	O
bowel	bowel	NN	B-NP	O
movement	movement	NN	I-NP	O
and	and	CC	O	O
advanced	advance	VBD	B-VP	O
diet	diet	NN	B-NP	O
to	to	TO	B-PP	O
mechanical	mechanical	JJ	B-NP	O
soft	soft	JJ	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
on	on	IN	B-PP	O
postop	postop	NN	B-NP	O
day	day	NN	I-NP	O
9	9	CD	I-NP	O
,	,	,	B-PP	O
and	and	CC	I-PP	O
on	on	IN	B-PP	O
postop	postop	NN	B-NP	O
day	day	NN	I-NP	O
13	13	CD	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
also	also	RB	B-ADVP	O
on	on	IN	B-PP	O
baby	baby	NN	B-NP	O
aspirin	aspirin	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
physical	physical	JJ	B-NP	O
examination	examination	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
x3	x3	NN	B-NP	O
.	.	.	O	O

Respiratory	Respiratory	JJ	B-ADJP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
clear	clear	JJ	B-ADJP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
lungs	lung	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
saturating	saturate	VBG	I-VP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
92	92	CD	B-NP	O
%	%	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
and	and	CC	O	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
position	position	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
bed	bed	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
requires	require	VBZ	B-VP	O
sometimes	sometimes	RB	B-ADVP	O
oxygen	oxygen	NN	B-NP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
nasal	nasal	JJ	B-NP	O
cannula	cannula	NN	I-NP	O
for	for	IN	B-PP	O
saturation	saturation	NN	B-NP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

Heart	Heart	NN	B-NP	O
rate	rate	NN	I-NP	O
is	be	VBZ	B-VP	O
controlled	control	VBN	I-VP	O
at	at	IN	B-PP	O
93	93	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
atenolol	atenolol	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
GI	GI	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
mechanical	mechanical	JJ	B-NP	O
soft	soft	JJ	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
abdomen	abdomen	NN	I-NP	O
is	be	VBZ	B-VP	O
nonpainful	nonpainful	JJ	B-ADJP	O
.	.	.	O	O

Nondistended	Nondistende	VBN	B-VP	O
.	.	.	O	O

Bowels	Bowel	NNS	B-NP	O
sounds	sound	NNS	I-NP	O
are	be	VBP	B-VP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
already	already	RB	I-VP	O
bowel	bowel	VB	I-VP	O
movement	movement	NN	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
passing	pass	VBG	I-VP	O
flatus	flatus	NN	B-NP	O
because	because	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
two	two	CD	I-NP	O
days	day	NNS	I-NP	O
three	three	CD	I-NP	O
bowel	bowel	NN	I-NP	O
movements	movement	NNS	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

C.	C.	NNP	B-NP	O
diff	diff	NN	I-NP	O
and	and	CC	I-NP	O
leucocytes	leucocyte	NNS	I-NP	B-cell_type
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
so	so	RB	B-ADJP	O
far	far	RB	I-ADJP	O
negative	negative	JJ	I-ADJP	O
.	.	.	O	O

GU	GU	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
back	back	RB	B-ADVP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	B-protein
Lasix	Lasix	NN	I-NP	I-protein
80	80	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
x1	x1	NN	I-NP	I-protein
plus	plus	CC	O	O
spironolactone	spironolactone	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
voiding	void	VBG	I-VP	O
fine	fine	NN	B-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
problem	problem	NN	I-NP	O
in	in	IN	B-PP	O
urinating	urinate	VBG	B-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
Foley	Foley	NNP	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
no	no	DT	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
back	back	RB	B-ADVP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
3.5	3.5	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
yesterday	yesterday	NN	B-NP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
back	back	RB	B-ADVP	O
on	on	IN	B-PP	O
baby	baby	NN	B-NP	O
aspirin	aspirin	NN	I-NP	O
also	also	RB	B-ADVP	O
at	at	IN	B-PP	O
81	81	CD	B-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
on	on	IN	B-PP	O
subcutaneous	subcutaneous	JJ	B-NP	O
heparin	heparin	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
as	as	IN	B-PP	O
prophylaxis	prophylaxis	NN	B-NP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
on	on	IN	B-PP	O
pneumo	pneumo	NN	B-NP	O
boots	boot	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
recent	recent	JJ	I-NP	O
labs	lab	NNS	I-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
are	be	VBP	B-VP	O
glucose	glucose	NN	B-NP	O
100	100	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	O
of	of	IN	B-PP	O
6	6	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
0.8	0.8	CD	I-NP	O
,	,	,	O	O
sodium	sodium	NN	B-NP	O
144	144	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
3.3	3.3	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
potassium	potassium	NN	I-NP	O
today	today	NN	B-NP	O
.	.	.	O	O

Chloride	Chloride	NN	B-NP	O
is	be	VBZ	B-VP	O
104	104	CD	B-NP	O
,	,	,	O	O
CO2	CO2	NN	B-NP	O
32	32	CD	I-NP	O
,	,	,	O	O
anion	anion	NN	B-NP	O
gap	gap	NN	I-NP	O
8	8	CD	I-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	O
8	8	CD	I-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
1.8	1.8	CD	I-NP	O
.	.	.	O	O

PTT	PTT	NN	B-NP	B-protein
34.7	34.7	CD	I-NP	I-protein
,	,	,	O	O
PTT	PTT	NN	B-NP	B-protein
6.3	6.3	CD	I-NP	I-protein
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
3.5	3.5	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
medications	medication	NNS	I-NP	O
:	:	:	O	O
Flovent	Flovent	NNP	B-NP	O
220	220	CD	I-NP	O
,	,	,	O	O
INH	INH	NNP	B-NP	O
x2	x2	CD	I-NP	O
,	,	,	O	O
Pepcid	Pepcid	NNP	B-NP	O
p.o.	p.o.	VBP	B-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
subcutaneous	subcutaneous	JJ	B-NP	O
heparin	heparin	NN	I-NP	O
5000	5000	CD	B-NP	O
units	unit	NNS	I-NP	O
b.i.d.	b.i.d.	NN	B-NP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
50	50	CD	I-NP	O
x2	x2	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
Seroquel	Seroquel	NNP	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
x1	x1	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	O
scale	scale	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
spironolactone	spironolactone	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Simvastatin	Simvastatin	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
x1	x1	NN	I-NP	I-protein
,	,	,	O	O
baby	baby	NN	B-NP	O
aspirin	aspirin	NN	I-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
albuterol	albuterol	NN	B-NP	O
at	at	IN	B-PP	O
2.5	2.5	CD	B-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
12h	12h	NN	I-NP	O
.	.	.	O	O

and	and	CC	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
Zofran	Zofran	NN	B-NP	O
for	for	IN	B-PP	O
nausea	nausea	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
no	no	DT	B-NP	O
pain	pain	NN	I-NP	O
medication	medication	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Ulysses	Ulysses	NNP	I-NP	O
Gunnett	Gunnett	NNP	I-NP	O
in	in	IN	B-PP	O
three	three	CD	B-NP	O
weeks	week	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
restart	restart	VB	I-VP	O
her	her	PRP$	B-NP	O
Humulin	Humulin	NN	I-NP	O
dose	dose	NN	I-NP	O
for	for	IN	B-PP	O
glucose	glucose	NN	B-NP	O
control	control	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
anticoagulation	anticoagulation	NN	B-NP	O
and	and	CC	O	O
therefore	therefore	RB	B-ADVP	O
begin	begin	VB	B-VP	O
Coumadin	Coumadin	NN	B-NP	O
for	for	IN	B-PP	O
INR	INR	NN	B-NP	O
range	range	NN	I-NP	O
between	between	IN	B-PP	O
2	2	CD	B-NP	O
and	and	CC	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
4-7633680	4-7633680	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
RADEN	RADEN	NN	B-NP	B-protein
,	,	,	O	O
WILBERT	WILBERT	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BRANTINGHAM	BRANTINGHAM	NNP	B-NP	O
,	,	,	O	O
QUINTON	QUINTON	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
7033981	7033981	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
10/30/04	10/30/04	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/30/04	10/30/04	CD	B-NP	O

